243
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Association of endothelial microparticle with NO, eNOS, ET-1, and fractional flow reserve in patients with coronary intermediate lesions

, , , , , , , & show all
Pages 429-435 | Received 09 Apr 2015, Accepted 31 Aug 2015, Published online: 10 Nov 2015
 

Abstract

Endothelial microparticle (EMP) is a biomarker for endothelial dysfunction. The aim of this study is to investigate the utility of EMP in evaluating coronary intermediate lesions. Participants included 49 patients with coronary intermediate lesions and 24 subjects with normal coronary arteries. Among these subjects, 28 patients accepted fractional flow reserve (FFR). Results showed that level of EMP was significantly higher in the intermediate lesion group. No correlation was found between EMP and FFR value, suggesting that circulating EMP is a systemic marker rather than a focal one.

Acknowledgements

Special thanks to Chung-Kuao Chou (Yuan’s General Hospital, Taiwan) and Xuguo Zhou (University of Kentucky) for their corrections and opinions in manuscript writing.

Declaration of interest

This project was supported by the Leading Academic Discipline Project of Beijing Education Bureau and Beijing Natural Sciences Foundation (7122200), Grants 2011CB503900 from “973” National S&T Major Project, Grants 81170101, 81370235 from the National Natural Science Foundation of China, and Grants 7122106 from the Natural Science Foundation of Beijing, China.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.